According to a study published by Insure Insights, the single-cell analysis is projected to grow at a CAGR of 16.5% during the forecast period. It was assumed that each cell type has a distinct lineage and function. However, it was studies found that each cell may be genetically and morphologically identical but are heterogenous differing dramatically. These differences play an important role in the health and functioning of the entire population. Single-cell analysis is the study of cell-to-cell variation within a cell population (cell culture, tissue, and organ).  Single-cell analysis is significant in understanding and studies various diseases such as cancer. Besides, the study of physiological functions in embryos and adults, drug development, and diseases include single-cell analysis.

Top Driver: Wide Application and Technological Advancements

Single-cell analysis plays a crucial role in microbiology and is the major factor driving the single-cell analysis market. The study of genomics and metabolomics has boomed in recent years, thereby stimulating the single-cell analysis market worldwide. Moreover, single-cell analysis has extended its application in various sectors of healthcare and pharmaceutical studies. Advancements in microbiology have encouraged and driven the market on a huge scale.

In addition, other factors, such as the growing geriatric population, rising prevalence of infectious as well as chronic diseases, have encouraged the government to incur investment in research and development. Also, the demand for personalized medication and the presence of technological advancements in the transcriptomics and proteomics procedure has resulted in the adoption of single-cell analysis at a huge scale.

Research Application Segment Anticipated to Witness Growth During the Forecast Period

Based on the application, the single-cell analysis market has been segmented into a research application and medical application. The research application segment accounts for the largest market share and is anticipated to grow at a significant pace during the forecast period. The growth is attributed to factors such as the rising prevalence of chronic diseases, which has created an urgent need for early detection of diseases, and the need for stem cell research have fueled the market. Also, the rising incidence of cancer has been a major factor impacting the growth of the market. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Hence all these factors are anticipated to grow the single-cell analysis market during the forecast period.

By the product, the market is segmented into consumables and instruments. Consumables accounts for the largest market share owing to the wide application of reagents such as probing, sorting, and identification.

By the end user, the market is segmented into Academic and Research laboratories, Biotechnology and Pharmaceutical companies, Hospital and Diagnostic laboratories. Advance technology and rising number of researches have contributed to the growth of academic and research laboratories segment.

Improved Healthcare Infrastructure and Presence of Significant Players to Benefit North America Market

North America is the prominent region accounting for the largest market share in the global single-cell analysis market. Factors attributing to the growth are technological advancements and advance healthcare infrastructure supporting research and development. In addition, the presence of significant players and government support has propelled the biotechnology and pharmaceutical industry in this region.

Following North America, Asia Pacific is anticipated to create a lucrative market in the upcoming forecast years. The developing economies such as India, China, and South Korea with skilled laborers, developing healthcare infrastructure, and government initiatives are expected to stimulate the single-cell analysis market in the Asia Pacific.

Players to Focus on Product Innovation and Strategic Acquisition

Significant players operating in the global single-cell analysis market are Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Bio-Rad Laboratories, Inc., Merck Millipore GmbH, Fluidigm, 10x Genomics, Inc., BGI, and Novogene Corporation.

Illumina Inc.: In January 2020, Illumina Inc. announced a strategic partnership with Roche and introduced a new sequencing system. The NextSeq 1000 and NextSeq 2000 Sequencing Systems are equipped with on-instrument integrated informatics for rapid secondary analysis. The new systems are designed to incorporate more than 75 innovations, including the commercialized combination of super resolution and blue chemistry, that enables a substantial increase in density and throughput as well as a reduction in operating costs.

Bio-Rad Laboratories:  In April 2020, Bio-Rad Laboratories announced to acquire Celsee, Inc., a company that offers instruments and consumables for the detection, isolation, and analysis of single cells. Innovative products and technologies of Celsee will extend Bio-Rad’s reach into the rapidly growing world of precision medicine and single-cell analysis, both of which offer enhanced insight into disease, diagnosis, and treatment.

Scope of the Report

By product  

• Consumables
• Reagents
• Instruments
• Microscope

By Application

• Research application
• Medical application

By End-User

• Biotechnological and Pharmaceutical Companies
• Academic and Research Laboratories
• Hospital and Diagnostic Laboratories

By Region

• North America
• Europe
• Asia Pacific
• SAMEA

Key Reasons to Purchase this Report

1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow